Meisam Bakhshayeshi

Meisam is Head of Process Development at Intergalactic Therapeutics, leading design, development, optimization, and tech transfer of C3DNA Drug Substance and Drug Product manufacturing processes to enable the Intergalactic pipeline. Meisam has extensive experience in process development and manufacturing across therapeutic modalities, including protein biologics, AAV viral vectors, plasmid DNA, and lipid nanoparticles. He was most recently Director, Process Development at Tessera Therapeutics, where he led the process development and manufacturing activities for AAV, plasmid DNA, and lipid nanoparticles. Prior to Tessera, he spent 10 years at Biogen in process development roles of increasing scope and responsibilities, including Head of Downstream Process Development for gene therapy and CMC Technical Development Lead for early- and late-stage gene therapy programs. Meisam holds a Ph.D. in Chemical Engineering from Penn State and a M.S and B.S. in Chemical Engineering from Sharif University of Technology in Iran.